Are you Dr. Srinivasan?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 24 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
9000 Rockville Pike
Bldg 10 Crc Room 2-5950
Bethesda, MD 20892Phone+1 301-496-6353Fax+1 301-402-0922- Is this information wrong?
Summary
- Dr. Ramaprasad Srinivasan, MD is a general surgeon in Bethesda, Maryland. He is currently licensed to practice medicine in Virginia.
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1999 - 2002
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1997 - 1999
Stony Brook Medicine/University HospitalInternship, Internal Medicine, 1996 - 1997
Bangalore Medical CollegeClass of 1991
Certifications & Licensure
VA State Medical License 2000 - 2024
Clinical Trials
- Stem Cell Transplant Therapy With Campath-1H for Treating Advanced Mycosis Fungoides and Sezary Syndrome Start of enrollment: 2002 Jul 30
- Prospective Randomized Comparative Study of Cell Transfer Therapy Using CD8+-Enriched Short-Term Cultured Anti-Tumor Autologous Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen Compared to High-Dose Aldesleukin in M... Start of enrollment: 2010 Apr 01
- A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer Start of enrollment: 2010 May 06
- Join now to see all
Publications & Presentations
PubMed
- Special populations in metastatic renal cell carcinoma.Ilana Goldberg, Yusuf Acikgoz, Taylor Goodstein, Elshad Hasanov, Ramaprasad Srinivasan, Eric A Singer> ;Current Opinion in Oncology. 2024 May 1
- Belzutifan for von Hippel-Lindau Disease: Pancreatic Lesion Population of the Phase 2 LITESPARK-004 Study.Lliopoulos, O., Beckermann, K., Oudard, S., Iversen, A., Goldberg, C., Fu, W., Perini, R., Liu, Y., Linehan, W., Else, T., Jonasch, E., Narayan, V., Maughan, B., Maran...> ;Clinical Cancer Research. 2024 Feb 23
- 2 citationsPRDM10 RCC: A Birt-Hogg-Dubé-like Syndrome Associated With Lipoma and Highly Penetrant, Aggressive Renal Tumors Morphologically Resembling Type 2 Papillary Renal Cell ...Laura S Schmidt, Cathy D Vocke, Christopher J Ricketts, Zoë Blake, Kristin K Choo, Deborah Nielsen, Rabindra Gautam, Daniel R Crooks, Krista L Reynolds, Janis L Krolus...> ;Urology. 2023 Sep 1
- Join now to see all
Press Mentions
Belzutifan Active in Von Hippel-Lindau Disease-Associated Renal Cell CarcinomaNovember 24th, 2021- No Benefit with Adjuvant Sorafenib in intermediate-/high-risk RCCNovember 2nd, 2020
